EDITAS MEDICINE INC
EDITNASDAQ🏆 #2932 by market capEarnings Nov 9US Equity
$2.95▲ $0.34 (+13.03%)
🌅 Pre-market$2.92▼ 1.02%Regular close · extended-hours price shownTrack EDIT
Get earnings, price moves & breaking news on Telegram
24h▲ 13.0%
7d▲ 18.7%
14d▲ 21.1%
30d▲ 13.7%
ytd▲ 43.6%
1y▼ 3.0%
🏦Market Cap
$453M
Small Cap
📈Revenue Growth (YoY)
20.8%
Healthy
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
9.5x
Elevated
Otter Score
—
Insufficient data
EDITAS MEDICINE INC
EDITAnalyst Ratings
Price
$2.95
Total
26
Raised
7
Lowered
3
Avg PT
$5.00
H / L
$6 / $4
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Wells Fargo | Upgraded | Equal Weight → Overweight | 2026-10-08 | $6.00 | +103.40% |
Guggenheim | Upgraded | Neutral → Buy | 2026-09-23 | $5.00 | +69.50% |
Chardan Capital | Reiterated | Buy | 2026-05-05 | $4.00 | +35.60% |
Jones Trading | Upgraded | Hold → Buy | 2026-03-10 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2025-09-05 | — | — |
Baird | Reiterated | Outperform | 2025-08-13 | — | — |
JP Morgan | Downgraded | Neutral → Underweight | 2024-12-16 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2024-12-16 | — | — |
RBC Capital | Reiterated | Sector Perform | 2024-12-13 | $14.00 | +374.60% |
Stifel | Downgraded | Buy → Hold | 2024-12-13 | — | — |
Barclays | Reiterated | Equal Weight | 2024-12-13 | $5.00 | +69.50% |
Truist Securities | Reiterated | Buy | 2024-11-05 | — | — |
B of A Securities | Upgraded | Neutral → Buy | 2024-08-08 | — | — |
Oppenheimer | Reiterated | Perform | 2024-06-18 | $12.00 | +306.80% |
Citigroup | Reiterated | Buy | 2024-05-09 | $11.00 | +272.90% |
Morgan Stanley | Upgraded | Underweight → Equal Weight | 2024-05-09 | $7.00 | +137.30% |
Cantor Fitzgerald | Downgraded | Overweight → Neutral | 2023-10-17 | — | — |
Raymond James | Upgraded | Market Perform → Outperform | 2023-06-13 | — | — |
Credit Suisse | Reiterated | Neutral | 2023-05-08 | $13.00 | +340.70% |
SVB Leerink | Reiterated | Market Perform | 2023-01-23 | — | — |
Goldman Sachs | Reiterated | Sell | 2022-05-24 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-06-18 | — | — |
BTIG Research | Reiterated | Buy | 2019-02-08 | — | — |
Jefferies | Upgraded | Hold → Buy | 2016-08-10 | — | — |
JMP Securities | Reiterated | Outperform | 2016-02-29 | — | — |
Cowen & Co. | Reiterated | Outperform | 2016-02-29 | — | — |
Institution
Wells Fargo
Upgraded · Equal Weight → Overweight · 2026-10-08
$6.00
+103.40%
Guggenheim
Upgraded · Neutral → Buy · 2026-09-23
$5.00
+69.50%
Chardan Capital
Reiterated · Buy · 2026-05-05
$4.00
+35.60%
Jones Trading
Upgraded · Hold → Buy · 2026-03-10
—
—
HC Wainwright & Co.
Reiterated · Buy · 2025-09-05
—
—
Baird
Reiterated · Outperform · 2025-08-13
—
—
JP Morgan
Downgraded · Neutral → Underweight · 2024-12-16
—
—
Evercore ISI Group
Reiterated · Outperform · 2024-12-16
—
—
RBC Capital
Reiterated · Sector Perform · 2024-12-13
$14.00
+374.60%
Stifel
Downgraded · Buy → Hold · 2024-12-13
—
—
Barclays
Reiterated · Equal Weight · 2024-12-13
$5.00
+69.50%
Truist Securities
Reiterated · Buy · 2024-11-05
—
—
B of A Securities
Upgraded · Neutral → Buy · 2024-08-08
—
—
Oppenheimer
Reiterated · Perform · 2024-06-18
$12.00
+306.80%
Citigroup
Reiterated · Buy · 2024-05-09
$11.00
+272.90%
Morgan Stanley
Upgraded · Underweight → Equal Weight · 2024-05-09
$7.00
+137.30%
Cantor Fitzgerald
Downgraded · Overweight → Neutral · 2023-10-17
—
—
Raymond James
Upgraded · Market Perform → Outperform · 2023-06-13
—
—
Credit Suisse
Reiterated · Neutral · 2023-05-08
$13.00
+340.70%
SVB Leerink
Reiterated · Market Perform · 2023-01-23
—
—
Goldman Sachs
Reiterated · Sell · 2022-05-24
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-06-18
—
—
BTIG Research
Reiterated · Buy · 2019-02-08
—
—
Jefferies
Upgraded · Hold → Buy · 2016-08-10
—
—
JMP Securities
Reiterated · Outperform · 2016-02-29
—
—
Cowen & Co.
Reiterated · Outperform · 2016-02-29
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space